Bank of America
PTIXW

Bank of America’s Protagenic Therapeutics Warrant PTIXW Stock Holding History

Bank of America’s Portfolio PTIXW Stock Details PTIXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$2 – 8142
2025
Q3 		$2 Hold
100
– – ﹤0.01% 8264
2025
Q2 		$5 Buy
+100
New +$4 ﹤0.01% 8324
2024
Q3 		– Sell
-100
Closed -$1 – 8356
2024
Q2 		$1 Buy
+100
New +$2 ﹤0.01% 8179

Other funds holding PTIXW

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of America's PTIXW Position: Q4 2025 in Review

Bank of America sold out of Protagenic Therapeutics Warrant (PTIXW) in Q4 2025, closing a stake of 100 shares — an estimated $2 sold.

Bank of America first reported a position in PTIXW in Q2 2024 and held it in 3 quarters. The position peaked at $5 in Q2 2025. 3 funds tracked by Wall St. Rank hold PTIXW as of Q4 2025.

  • Bank of America reported no remaining Protagenic Therapeutics Warrant position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 100 Protagenic Therapeutics Warrant shares in Q4 2025, an estimated $2.
  • Bank of America first reported a position in Protagenic Therapeutics Warrant in Q2 2024 and held it in 3 quarters.
  • Bank of America's Protagenic Therapeutics Warrant position peaked at $5 in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Protagenic Therapeutics Warrant as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.